GlassScriptPhysician profile
Stephanie Anne Cooper
NPI 1750467189
$4,781.35
in general payments reported to CMS, 2019-2025
23 companies · $992 in 2025
The $992 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $521 · 2021: $907 · 2022: $757 · 2023: $915 · 2024: $690 · 2025: $992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,596.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,608.82 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $1,169.20 | 2020-2022 | |
| Galderma Laboratories, L.P. | $628.15 | 2020-2025 | Dysport |
| Incyte Corporation | $398.53 | 2024-2025 | Opzelura, Opzelura |
| Sun Pharmaceutical Industries INC. | $221.51 | 2020-2023 | Ilumya |
| Journey Medical Corporation | $125.00 | 2025 | |
| Janssen Biotech, INC. | $77.71 | 2023-2024 | Tremfya, Simponi Aria, Stelara |
| Medline Industries LP | $70.66 | 2025 | |
| Abbvie INC. | $69.33 | 2025 | |
| Polynovo North America LLC | $50.29 | 2024 | Novosorb Btm |
| Motiva USA, LLC | $47.12 | 2025 | |
| Lilly USA, LLC | $41.63 | 2023 | Taltz |
| Allergan, INC. | $40.93 | 2020-2022 | |
| Ucb, INC. | $30.70 | 2024 | Bimzelx |
| Musculoskeletal Transplant Foundation INC. | $29.46 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $29.18 | 2020-2022 | |
| Verrica Pharmaceuticals INC. | $24.81 | 2023 | Ycanth |
| Solta Medical, A Division of Bausch Health US, LLC | $24.45 | 2025 | |
| Almirall LLC | $23.48 | 2023 | Klisyri |
| Genzyme Corporation | $22.62 | 2023 | |
| Biofrontera INC. | $18.30 | 2022 | |
| Trevena, INC. | $15.87 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $13.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.